Blockade of Myeloid Suppressor Cells Overcomes the Anti-PD-1/PD-L1 Resistance in KRAS-Driven and LKB1-Deficient NSCLC

被引：0

作者：

Li, R. ^{[1
]}

Salehi-Rad, R. ^{[1
]}

Momcilovic, M. ^{[1
]}

Lim, R. ^{[1
]}

Ong, S. ^{[1
]}

Huang, Z. ^{[1
]}

Tran, L. ^{[1
]}

Zhe, J. ^{[1
]}

Paul, M. ^{[1
]}

Teitell, M. ^{[1
]}

Minna, J. ^{[2
]}

Krysan, K. ^{[1
]}

Shackelford, D. ^{[1
]}

Liu, B. ^{[1
]}

Dubinett, S. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA USA

[2] UTSW, Dallas, TX USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A11

引用

页码：S15 / S15

页数：1

共 50 条

[41] Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Hanna Grauers Wiktorin
Malin S. Nilsson
Roberta Kiffin
Frida Ewald Sander
Brianna Lenox
Anna Rydström
Kristoffer Hellstrand
Anna Martner
Cancer Immunology, Immunotherapy, 2019, 68 : 163 - 174
[42] Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Wiktorin, Hanna Grauers
Nilsson, Malin S.
Kiffin, Roberta
Sander, Frida Ewald
Lenox, Brianna
Rydstrom, Anna
Hellstrand, Kristoffer
Martner, Anna
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (02) : 163 - 174
[43] Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1-deficient Kras-driven lung tumorigenesis
Bhatt, Vrushank
Khayati, Khoosheh
Hu, Zhixian Sherrie
Lee, Amy
Kamran, Wali
Su, Xiaoyang
Guo, Jessie Yanxiang
GENES & DEVELOPMENT, 2019, 33 (3-4) : 150 - 165
[44] Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy
Bai, Rilan
Cui, Jiuwei
FRONTIERS IN IMMUNOLOGY, 2022, 13
[45] A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity
Shi, Wenqiang
Lv, Liangyin
Liu, Nan
Wang, Hui
Wang, Yang
Zhu, Wen
Liu, Zexin
Zhu, Jianwei
Lu, Huili
MOLECULAR THERAPY, 2023, 31 (01) : 66 - 77
[46] Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
Tan, Shuguang
Zhang, Catherine W-H
Gao, George F.
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2016, 1
[47] The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
Qian, Jiawen
Wang, Chen
Wang, Bo
Yang, Jiao
Wang, Yuedi
Luo, Feifei
Xu, Junying
Zhao, Chujun
Liu, Ronghua
Chu, Yiwei
JOURNAL OF NEUROINFLAMMATION, 2018, 15
[48] Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen
Alexander C. Huang
Wei Zhang
Gao Zhang
Min Wu
Wei Xu
Zili Yu
Jiegang Yang
Beike Wang
Honghong Sun
Houfu Xia
Qiwen Man
Wenqun Zhong
Leonardo F. Antelo
Bin Wu
Xuepeng Xiong
Xiaoming Liu
Lei Guan
Ting Li
Shujing Liu
Ruifeng Yang
Youtao Lu
Liyun Dong
Suzanne McGettigan
Rajasekharan Somasundaram
Ravi Radhakrishnan
Gordon Mills
Yiling Lu
Junhyong Kim
Youhai H. Chen
Haidong Dong
Yifang Zhao
Giorgos C. Karakousis
Tara C. Mitchell
Lynn M. Schuchter
Meenhard Herlyn
E. John Wherry
Xiaowei Xu
Wei Guo
Nature, 2018, 560 : 382 - 386
[49] Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
de Jong, Florus C.
Rutten, Vera C.
Zuiverloon, Tahlita C. M.
Theodorescu, Dan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 15
[50] Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
Shuguang Tan
Catherine W-H Zhang
George F Gao
Signal Transduction and Targeted Therapy, 1

← 1 2 3 4 5 →